Observational Study to Evaluate the Actual Use of Elidel ® in Chinese Patients With Mild to Moderate Atopic Dermatitis
Condition: Atopic Dermatitis Intervention: Drug: Pimecrolimus 1% Top Cream Sponsors: Mylan Inc.; Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2021 Category: Research Source Type: clinical trials